论文部分内容阅读
全国血吸虫病科学研究委员会第二次会议根据各重点实验单位的报告,认真负责的研究了各种短程疗法的临床资料,经过反复的讨论后,决定要在全国范围内推行“三日疗法”治疗血吸虫病。我们估计约有全部病员数字的三分之一以上可以接受三日疗法得到治疗。这是血吸虫病疗法上的一大进步,无疑的是病员的一大喜讯。酒石酸锑钾(钠)治疗血吸虫病的疗效,假使其他条件相同,无疑的,是与剂量成正比,剂量愈大疗效愈好。但是剂量提高毒性反应就增加了,必须延长疗程才能保证安全。疗程延长势必影响生产,增加治疗费用,对病员以及国家
The second meeting of the National Schistosomiasis Scientific Research Committee studied the clinical data of various short-course treatments carefully and responsibly according to the reports of key experimental units. After repeated discussions, it decided to launch the “three-day treatment” nationwide Schistosomiasis. We estimate that about one-third of all patient numbers can be treated for three days. This is a big improvement in the treatment of schistosomiasis, which undoubtedly is a great news for patients. Antimony potassium tartrate (sodium) treatment of schistosomiasis effect, if other conditions are the same, no doubt, is proportional to the dose, the greater the better the effect of the dose. However, the dose increased toxic response increased, the course must be extended to ensure safety. Prolonged treatment is bound to affect the production, increase treatment costs, the sick and the country